All Journals > The Journal of Infectious Diseases > 1 December 2006 > Protection against Rotavirus by Lactobodies

Article Tools

Search for Related Articles

  • By Author
  • Search In

Press Release

Unique Collaboration Charts the Migrations of a Parasite that Affected History
Researchers Sequence Louse DNA from Mummies and Propose New Model for its Development


In the News

Featured in Scientific American
"Stomach Bug May Ward Off Asthma" July 16, 2008
Helicobacter pylori Colonization Is Inversely Associated with Childhood Asthma
Yu Chen, Martin J. Blaser
"...scientists analyzed data from more than 7,000 participants in a national health and nutrition survey. They found that children between the ages of three and 13 are less than half as likely to have asthma if they carry H. pylori. They also had half the incidence of hay fever and other allergies. The results appear online in the July 15th issue of The Journal of Infectious Diseases."

Featured in U.S. News & World Report
"Stomach Germ May Protect Against Asthma" July 15, 2008
Helicobacter pylori Colonization Is Inversely Associated with Childhood Asthma

Yu Chen, Martin J. Blaser
"A stomach bacterium called Helicobacter pylori may reduce a child's risk of developing asthma by as much as 50 percent, a new study suggests.  H. pylori has been present in the human stomach probably since humans were humans. However, the germ began disappearing over the course of the 20th century with the introduction of antibiotics and cleaner water and homes, perhaps making children more susceptible to asthma, the study authors suggested."

Featured in Wired News
"Internal Bacterial Imbalance Leads to Asthma" July 15, 2008
Helicobacter pylori Colonization Is Inversely Associated with Childhood Asthma
Yu Chen, Martin J. Blaser
"In a study published yesterday in the Journal of Infectious Diseases, researchers showed that Heliobacter pylori, an intestinal microbe that co-evolved with humans, appears to protect children from asthma.  Asthma rates have nearly doubled in the United States since 1970, and are swelling in the developing world. Underlying the rise is a constellation of causes -- and one of these may be the loss of H. pylori, a vanishing member of the rich bacterial ecosystems in our stomachs."

Featured in Reuters
"Zinc reduces common cold symptoms" April 17, 2008
Duration and Severity of Symptoms and Levels of Plasma Interleukin-1 Receptor Antagonist, Soluble Tumor Necrosis Factor Receptor, and Adhesion Molecules in Patients with Common Cold Treated with Zinc Acetate
Ananda S. Prasad, Frances W. J. Beck, Bin Bao, Diane Snell, and James T. Fitzgerald
Zinc acetate lozenges taken within 24 hours of developing symptoms of the common cold reduce the duration and severity of symptoms, according to a report in The Journal of Infectious Diseases.

Featured in National Public Radio
"Peruvian Mummies' Lice Came from Africa" February 7, 2008
Molecular Identification of Lice from Pre-Columbian Mummies

Didier Raoult, David L. Reed, Katharina Dittmar, Jeremy J. Kirchman, Jean-Marc Rolain, Sonia Guillen, and Jessica E. Light
When humans migrated out of Africa 100,000 years ago, they were likely carrying stowaways. Scientists who've tested head lice taken from Peruvian mummies found the strains of these little parasites were nearly identical to those that were irritating our ancestors in Africa.

Featured in New York Times
"Scientists Say Mummies' Lice Show Pre-Columbian Origins" February 7, 2008
Molecular Identification of Lice from Pre-Columbian Mummies
Didier Raoult, David L. Reed, Katharina Dittmar, Jeremy J. Kirchman, Jean-Marc Rolain, Sonia Guillen, and Jessica E. Light
[In a new paper for the JID, scientists] establish that lice had accompanied their human hosts in the original peopling of the Americas, probably as early as 15,000 years ago. The DNA matched that of the most common type of louse known to exist worldwide now and also before Europeans colonized the New World.

Featured in Reuters
"Head lice came with us out of Africa" February 6, 2008
Molecular Identification of Lice from Pre-Columbian Mummies
Didier Raoult, David L. Reed, Katharina Dittmar, Jeremy J. Kirchman, Jean-Marc Rolain, Sonia Guillen, and Jessica E. Light
Head lice taken from 1,000-year-old mummies in Peru support the idea that the little creatures accompanied humans on their first migration out of Africa, 100,000 years ago, researchers reported on Wednesday.

1 December 2006

Volume 194, Number 11
The Journal of Infectious Diseases 2006;194:1580–1588
0022-1899/2006/19411-0016$15.00
DOI: 10.1086/508747
MAJOR ARTICLE

Lactobacilli Expressing Variable Domain of Llama Heavy-Chain Antibody Fragments (Lactobodies) Confer Protection against Rotavirus-Induced Diarrhea

Neha Pant,1,a

Anna Hultberg,1,a

Yaofeng Zhao,1

Lennart Svensson,2

Qiang Pan-Hammarström,1

Kari Johansen,3

Peter H. Pouwels,5

Franco M. Ruggeri,8

Pim Hermans,6

Leon Frenken,7

Thomas Borén,4

Harold Marcotte,1 and

Lennart Hammarström1

1Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska Huddinge, Stockholm, 2Division of Molecular Virology, University of Linköping, Linköping, 3Department of Virology, Swedish Institute for Infectious Disease Control, Karolinska Institutet, Solna, and 4Department of Medical Biochemistry and Biophysics, Umeå University, Umeå, Sweden; 5TNO, Prevention and Health, Division of Immunology and Infectious Disease, Leiden, 6BAC BV, Naarden, and 7Unilever Foods and Health Research Institute, Vlaardingen, The Netherlands; 8Laboratorio di Ultrastrutture, Instituto Superiore di Sanitá, Rome, Italy

Background.  Rotavirus-induced diarrhea poses a worldwide medical problem in causing substantial morbidity and mortality among children in developing countries. We therefore developed a system for passive immunotherapy in which recombinant lactobacilli constitutively express neutralizing variable domain of llama heavy-chain (VHH) antibody fragments against rotavirus.

Methods.  VHH were expressed in Lactobacillus paracasei, in both secreted and cell surface–anchored forms. Electron microscopy was used to investigate the binding efficacy of VHH-expressing lactobacilli. To investigate the in vivo function of VHH-expressing lactobacilli, a mouse pup model of rotavirus infection was used.

Results.  Efficient binding of the VHH antibody fragments to rotavirus was shown by enzyme-linked immunosorbent assay and scanning electron microscopy. VHH fragments expressed by lactobacilli conferred a significant reduction in infection in cell cultures. When administered orally, lactobacilli-producing surface-expressed VHH markedly shortened disease duration, severity, and viral load in a mouse model of rotavirus-induced diarrhea when administered both fresh and in a freeze-dried form.

Conclusions.  Transformed lactobacilli may form the basis of a novel form of prophylactic treatment against rotavirus infections and other diarrheal diseases.

Received 10 February 2006; accepted 10 June 2006; electronically published 23 October 2006.

  • Potential conflict of interest: Unilever has applied for a patent on the use of VHH for the mitigation of rotavirus-induced diarrhea.

    Financial support: Swedish International Development Agency; Swedish Research Council; European Union ADRI (project QLK2-CT-2001-01216); Swedish Agency for Research in Developing Countries.

  • aN.P. and A.H. contributed equally to the work.

Reprints or correspondence: Prof. Lennart Hammarström, Div. of Clinical Immunology, Karolinska Institutet at Karolinska University Hospital Huddinge, SE-141 86, Stockholm, Sweden ().

Cited by

Harold Marcotte, Neha Pant, Lennart Hammarström. (2008) Engineered lactobody-producing lactobacilli: a novel form of therapy against rotavirus infection. Future Virology 3:4, 327-341
Online publication date: 1-Aug-2008.
CrossRef
M. M. Harmsen, H. J. Haard. (2007) Properties, production, and applications of camelid single-domain antibody fragments. Applied Microbiology and Biotechnology 77:1, 13-22
Online publication date: 9-Nov-2007.
CrossRef
Ulrich Desselberger. (2007) Second European Rotavirus Biology Meeting. Future Virology 2:5, 429-435
Online publication date: 1-Oct-2007.
CrossRef
Close Popup